Published in
American Association for the Advancement of Science, Science Translational Medicine, 616(13), 2021
DOI: 10.1126/scitranslmed.abe8939
Links
Tools
Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors
Journal article published in 2021 by
Sophie C. Cazanave 
,
Andrew D. Warren ,
Maciej Pacula,
Fayçal Touti,
Anna Zagorska,
Nil Gural,
Eric K. Huang ,
Sarah Sherman,
Mehar Cheema,
Sabrina Ibarra ,
Jamie Bates ,
Andrew N. Billin,
John T. Liles,
Grant R. Budas,
David G. Breckenridge
and other authors.
,
Andrew D. Warren ,
Maciej Pacula,
Fayçal Touti,
Anna Zagorska,
Nil Gural,
Eric K. Huang ,
Sarah Sherman,
Mehar Cheema,
Sabrina Ibarra ,
Jamie Bates ,
Andrew N. Billin,
John T. Liles,
Grant R. Budas,
David G. Breckenridge
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
A urinary test for liver protease activity detects NASH fibrosis and indicates early therapeutic treatment response.